Report Details:
15 Companies Covered
128 Pages
HLA Typing Market Highlights
The HLA Typing Market reached USD 0.85 billion in 2025 and is positioned to climb toward USD 1.78 billion by 2035, advancing at a 7.65% CAGR across the 2026–2035 forecast window from a 2026 starting base near USD 0.91 billion.
The demand for HLA typing to reduce the risk of transplant rejection has increased due to the rising global burden of chronic diseases, including acute and chronic hepatitis, coronary artery disease, end-stage renal disease, chronic kidney disease, and chronic renal disease among people of all ages. High-throughput simultaneous screening of numerous genes is made possible by next-generation sequencing (NGS) technologies, which also dramatically lower consumable costs. HLA typing integration in the field of customized immunotherapy is anticipated to be a significant advancement.
Key Players
MRFR recognizes the following companies as the key players in the global HLA Typing market— Bio-Rad Laboratories, Inc. (US), F Hoffmann-La Roche Ltd (Switzerland), QIAGEN V (Netherlands), Thermo Fisher Scientific Inc. (US), and bioMérieux SA (France).
Segment Analysis
The global HLA Typing market has been segmented based on Technology, Product & Service, Application and End-user.
On the basis of technology, the market is segmented into Molecular Assay Technologies and Non-molecular Assay Technologies. The molecular assay technologies segment was attributed to holding the largest market share in 2024. The reason molecular tests are useful for identifying infectious disorders is because they have a high sensitivity and specificity.
On the basis of product & Service, the market is segmented into Reagents & Consumables, Instruments, and Software & Services. The Instruments segment was attributed to holding the largest market share in 2024. This is a result of their growing utility and affordability.
Based on application, the global HLA Typing market has been segmented into Diagnostic Applications, Research Applications, Donor-recipient cross-matching, Infectious disease testing, Cancer diagnosis & prevention, Transfusion therapy, and other diagnostic applications. The Diagnostic Applications segment was expected to hold the largest market share in 2024. This is due to the increasing prevalence of using HLA typing in the diagnosis of rare and chronic illnesses.
Based on end-user, the global HLA Typing market has been segmented into Commercial service providers, Hospitals & surgical centers and Research laboratories & academic institutes. The Hospitals & surgical centers segment was expected to hold the largest market share in 2024. This is a result of both the growing patient base and the increasing number of transplant procedures performed in hospitals.
Regional Analysis
The global HLA Typing market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World. North America consists of the US and Canada. The Europe HLA Typing market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The HLA Typing market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World HLA Typing market comprises the Middle East, Africa, and Latin America.
The largest market share for HLA Typing was maintained by the North American regional sector. This is because North America, which accounted for a portion of sales, is anticipated to see a significant revenue increase during the course of the forecast. Growth can be attributed to a number of factors, including rising investment in HLA research, a rise in the prevalence of chronic diseases, the existence of a developed healthcare system and modern healthcare infrastructure, the quick adoption of cutting-edge transplant technologies, an increase in the number of organ transplant procedures performed, and the strong presence of important players in the area. Furthermore, there is swift progress in technology in transplant diagnosis and the growing prevalence of medical devices.
Moreover, the Europe market has been persistently growing over the forecast period. The demand Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS), two technological developments in HLA typing techniques, have increased the efficiency, speed, and accuracy of HLA typing testing. Market expansion is fueled by the use of these cutting-edge technologies in European laboratories.
Additionally, because of the improved infrastructure of healthcare facilities, thoughtfully crafted reimbursement policies and the rising growth of economic elements that have a favorable impact on the industry, Asia Pacific is predicted to have the quickest growth in the human leukocyte antigen matching market. Modern labs with cutting-edge technology will propel the market along with the growing number of transplant hospitals and qualified personnel.
Furthermore, the rest of the world's HLA Typing market is divided into the Middle East, Africa, and Latin America. The growth is due to the rising global burden of chronic diseases, including acute and chronic hepatitis. Government support, a rise in investor interest, and the viability of the technology in the sector are all contributing factors to the market expansion.
Key Findings of the Study
- Diagnostic testing dominates application demand within the HLA Typing Market, contributing roughly USD 0.58 billion in 2025
- Research applications are expanding at a 9.65% CAGR as immune gene matching enters drug discovery pipelines
- Commercial service providers lead end-user demand with a 43.5% share
- North America retains dominance with a 41.8% revenue share of the HLA Typing Market
- Asia-Pacific posts the fastest regional expansion at a 9.45% CAGR
